Hepatocyte insulin resistance promotes hyperglycemia and enhances more compensatory insulin production, which prompts DNL by activation of carbohydrate-response element binding protein (ChREBP) and sterol regulatory element binding protein-1c (SREBP-1c) (113). This evidence concerns the gene INS and Hyperglycemia.